SNDX Syndax Pharmaceuticals, Inc. gains 36% Mar 28, 2018
Developing a therapy that enhances checkpoint immuno-oncology drugs. http://www.priceseries.com/trade/SNDX-Syndax-Pharmaceuticals-Inc-stock-gains-36-percent-a-Trade-Record-by-priceSeries-2018031220180328.html